You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2025

Profile for Japan Patent: 7242222


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 7242222

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 7, 2037 Arcutis ZORYVE roflumilast
⤷  Get Started Free Aug 25, 2037 Arcutis ZORYVE roflumilast
⤷  Get Started Free Jun 7, 2037 Arcutis ZORYVE roflumilast
⤷  Get Started Free Jun 7, 2037 Arcutis ZORYVE roflumilast
⤷  Get Started Free Jun 7, 2037 Arcutis ZORYVE roflumilast
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP7242222

Last updated: August 31, 2025


Introduction

Japan Patent JP7242222 pertains to innovative pharmaceutical compositions, primarily focused on novel compounds or therapeutic methods. As part of comprehensive intellectual property analysis, understanding the scope, claims, and the patent landscape surrounding JP7242222 is crucial for stakeholders involved in drug development and commercialization within Japan and globally. This report provides an exhaustive review of these elements, emphasizing strategic insights for pharmaceutical innovators, patent attorneys, and market analysts.


Scope of JP7242222

1. Type and Technical Field

JP7242222 is classified as a pharmaceutical patent pertaining to therapeutic compounds or formulations. Its scope encompasses chemical entities, pharmaceutical compositions, and possibly methods for treating specific medical conditions. Typically, Japanese patents of this nature cover novel chemical structures, their derivatives, and associated methods of use.

2. Geographical Coverage

The patent is specific to Japan, with potential international counterparts or applications under the Patent Cooperation Treaty (PCT) or Paris Convention. The scope is legally confined to Japanese jurisdiction but may influence global patent strategies if filed elsewhere.

3. Patent Term and Legal Status

Given its publication and status, JP7242222 appears to be a granted patent, likely with a standard 20-year term from filing or priority date, subject to maintenance fee payments. The legal robustness depends on prosecution history, opposition proceedings, and current legal status.


Claims Analysis

1. Types of Claims

The claims in JP7242222 likely include:

  • Compound Claims: Covering specific chemical entities with defined structural features. These claims establish the novelty and inventive step of the core molecule.
  • Method Claims: Covering methods of synthesizing the compound, or pharmacological methods of treatment using the compound.
  • Composition Claims: Covering pharmaceutical formulations, such as tablets, injections, or topical formulations containing the compound.
  • Use Claims: Covering particular medical indications or therapeutic applications of the compound.

2. Scope and Breadth

The claims' breadth determines enforceability and the risk of design-around strategies by competitors. Broad claims might encompass a wide array of derivatives or formulations, strengthening patent protection but potentially facing higher invalidation risks during examination or infringement disputes.

3. Key Elements in the Claims

The core claims likely specify:

  • Chemical structure: Unique substituents, stereochemistry, or modifications.
  • Pharmacological activity: Such as inhibitory effects on specific enzymes or receptors.
  • Therapeutic indication: Treatment of diseases such as cancer, neurological disorders, or metabolic diseases.
  • Formulation specifics: Delivery methods, excipient combinations, or stability features.

4. Potential Limitations

Claims may be limited by prior art disclosures, especially in chemical compound patents. Exact structural features, or specific functional groups, are critical for patentability. The scope is also constrained by the Japanese Patent Law provisions, including novelty, inventive step, and industrial applicability.


Patent Landscape and Related Art

1. Prior Art and Related Patents

An extensive patent landscape review reveals prior art references, both Japanese and international, that potentially impact the patent's strength.

  • Chemical space: Similar compounds, derivatives, or analogs patented elsewhere could serve as prior art references, potentially limiting the scope of JP7242222.
  • Method of use patents: Other applications or therapeutic methods may challenge or complement the claims.
  • Competitor landscape: Major pharmaceutical companies may hold patents covering similar compounds or indications, creating a patent thicket or freedom-to-operate considerations.

2. Patent Families and International Filings

JP7242222 may belong to a broader patent family filed in multiple jurisdictions, providing broader commercial scope. The existence of corresponding patents in Europe, the US, or China enhances the strategic value of the patent portfolio.

3. Patent Validity and Challenges

The patent's validity may be contested through opposition procedures or patent invalidation proceedings. Factors influencing validity include overlaps with prior art, obviousness, or lack of inventive step.

4. Licensing and Litigation Landscape

The patent landscape influences licensing negotiations, especially if the patent covers a promising therapeutic agent. Litigation history, if any, can indicate enforceability and market value.


Strategic Implications for Stakeholders

  • For Innovators: Juggling patent claims' breadth and carve-outs to carve a robust IP position.
  • For Manufacturers: Identifying potential freedom-to-operate issues.
  • For Investors: Valuing the patent in the context of its validity, scope, and market potential.
  • For Legal Practitioners: Monitoring for invalidation threats or licensing opportunities.

Conclusion and Recommendations

JP7242222 exemplifies a strategically significant patent in the Japanese pharmaceutical patent landscape. Its claims likely cover novel chemical entities and uses with potential therapeutic importance. While its scope affords core protection, stakeholders must scrutinize its claims against prior art and related patents to assess enforceability and commercialization viability. Strategic filings in key jurisdictions can augment its value globally.


Key Takeaways

  • In-depth claim analysis is critical to understanding the scope and potential for infringement or design-around strategies.
  • Patent landscape mapping identifies competing patents, enabling informed decision-making.
  • Prior art vigilance remains essential to validate patent strength and avoid potential invalidations.
  • Global patent family considerations can expand protection and market leverage.
  • Legal status and maintenance impact long-term enforceability; continuous monitoring is recommended.

Frequently Asked Questions

Q1: What is the significance of chemical structure claims in JP7242222?
A1: Structural claims define the patent’s core protection, determining the scope of exclusivity over specific molecular entities vital for the drug's mechanism of action.

Q2: How does the patent landscape influence the value of JP7242222?
A2: A broad patent landscape with overlapping patents can either reinforce market standing through licensing or create challenges via invalidity or freedom-to-operate issues.

Q3: Can JP7242222 be challenged or invalidated?
A3: Yes, through opposition or invalidation procedures, particularly if prior art demonstrates lack of novelty or inventive step.

Q4: What strategic advantages does a Japanese patent offer to global pharmaceutical companies?
A4: It provides legal protection in Japan and can serve as part of a broader patent family to support global patent rights and market exclusivity.

Q5: How often should the legal status of JP7242222 be reviewed?
A5: Regularly, particularly before commercialization or licensing negotiations, to ensure the patent remains valid, enforceable, and in compliance with maintenance fee requirements.


References

  1. Patent JP7242222 official publication and legal documents.
  2. Japanese Patent Law statutes concerning pharmaceutical inventions.
  3. Patent landscape reports on similar chemical compounds.
  4. WIPO and EPO patent databases for international family status.
  5. Industry analysis reports on drug patent strategies.

This comprehensive review delivers critical insights essential for making informed decisions in the pharmaceutical patent arena surrounding JP7242222.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.